Global Genomics Personalized Health 麻豆原创 Insights, Forecast to 2029

Publication ID:

PB504240253

Publication Date:

May 31, 2023

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.
麻豆原创 Analysis and Insights: Global Genomics Personalized Health 麻豆原创
The global Genomics Personalized Health market is projected to grow from US$ 10340 million in 2023 to US$ 16780 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.
The US & Canada market for Genomics Personalized Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Genomics Personalized Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Genomics Personalized Health is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Genomics Personalized Health include QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Genomics Personalized Health market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Genomics Personalized Health, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genomics Personalized Health, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genomics Personalized Health revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Genomics Personalized Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Genomics Personalized Health revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc.
By Company
QIAGEN
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Lonza
INVITAE
Genetic Technologies
Interleukin Genetics
Eastern Biotech
DNA Genotek
UBiome
XCode Life
Segment by Type
NGS Platforms
RT-PCR
Microarray
Genetic Analyzers
Segment by Application
Academics & Research Institutes
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Genomics Personalized Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomics Personalized Health companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genomics Personalized Health revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Genomics Personalized Health 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 NGS Platforms
1.2.3 RT-PCR
1.2.4 Microarray
1.2.5 Genetic Analyzers
1.3 麻豆原创 by Application
1.3.1 Global Genomics Personalized Health 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Academics & Research Institutes
1.3.3 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics Personalized Health 麻豆原创 Perspective (2018-2029)
2.2 Global Genomics Personalized Health Growth Trends by Region
2.2.1 Genomics Personalized Health 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomics Personalized Health Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Genomics Personalized Health Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Genomics Personalized Health 麻豆原创 Dynamics
2.3.1 Genomics Personalized Health Industry Trends
2.3.2 Genomics Personalized Health 麻豆原创 Drivers
2.3.3 Genomics Personalized Health 麻豆原创 Challenges
2.3.4 Genomics Personalized Health 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Genomics Personalized Health by Players
3.1.1 Global Genomics Personalized Health Revenue by Players (2018-2023)
3.1.2 Global Genomics Personalized Health Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Genomics Personalized Health 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Genomics Personalized Health, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Genomics Personalized Health 麻豆原创 Concentration Ratio
3.4.1 Global Genomics Personalized Health 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Personalized Health Revenue in 2022
3.5 Global Key Players of Genomics Personalized Health Head office and Area Served
3.6 Global Key Players of Genomics Personalized Health, Product and Application
3.7 Global Key Players of Genomics Personalized Health, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics Personalized Health Breakdown Data by Type
4.1 Global Genomics Personalized Health Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Genomics Personalized Health Forecasted 麻豆原创 Size by Type (2024-2029)
5 Genomics Personalized Health Breakdown Data by Application
5.1 Global Genomics Personalized Health Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Genomics Personalized Health Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Genomics Personalized Health 麻豆原创 Size (2018-2029)
6.2 North America Genomics Personalized Health 麻豆原创 Size by Type
6.2.1 North America Genomics Personalized Health 麻豆原创 Size by Type (2018-2023)
6.2.2 North America Genomics Personalized Health 麻豆原创 Size by Type (2024-2029)
6.2.3 North America Genomics Personalized Health 麻豆原创 Share by Type (2018-2029)
6.3 North America Genomics Personalized Health 麻豆原创 Size by Application
6.3.1 North America Genomics Personalized Health 麻豆原创 Size by Application (2018-2023)
6.3.2 North America Genomics Personalized Health 麻豆原创 Size by Application (2024-2029)
6.3.3 North America Genomics Personalized Health 麻豆原创 Share by Application (2018-2029)
6.4 North America Genomics Personalized Health 麻豆原创 Size by Country
6.4.1 North America Genomics Personalized Health 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Genomics Personalized Health 麻豆原创 Size by Country (2018-2023)
6.4.3 North America Genomics Personalized Health 麻豆原创 Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Genomics Personalized Health 麻豆原创 Size (2018-2029)
7.2 Europe Genomics Personalized Health 麻豆原创 Size by Type
7.2.1 Europe Genomics Personalized Health 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe Genomics Personalized Health 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe Genomics Personalized Health 麻豆原创 Share by Type (2018-2029)
7.3 Europe Genomics Personalized Health 麻豆原创 Size by Application
7.3.1 Europe Genomics Personalized Health 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe Genomics Personalized Health 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe Genomics Personalized Health 麻豆原创 Share by Application (2018-2029)
7.4 Europe Genomics Personalized Health 麻豆原创 Size by Country
7.4.1 Europe Genomics Personalized Health 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Genomics Personalized Health 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe Genomics Personalized Health 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Genomics Personalized Health 麻豆原创 Size (2018-2029)
8.2 China Genomics Personalized Health 麻豆原创 Size by Type
8.2.1 China Genomics Personalized Health 麻豆原创 Size by Type (2018-2023)
8.2.2 China Genomics Personalized Health 麻豆原创 Size by Type (2024-2029)
8.2.3 China Genomics Personalized Health 麻豆原创 Share by Type (2018-2029)
8.3 China Genomics Personalized Health 麻豆原创 Size by Application
8.3.1 China Genomics Personalized Health 麻豆原创 Size by Application (2018-2023)
8.3.2 China Genomics Personalized Health 麻豆原创 Size by Application (2024-2029)
8.3.3 China Genomics Personalized Health 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Genomics Personalized Health 麻豆原创 Size (2018-2029)
9.2 Asia Genomics Personalized Health 麻豆原创 Size by Type
9.2.1 Asia Genomics Personalized Health 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia Genomics Personalized Health 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia Genomics Personalized Health 麻豆原创 Share by Type (2018-2029)
9.3 Asia Genomics Personalized Health 麻豆原创 Size by Application
9.3.1 Asia Genomics Personalized Health 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia Genomics Personalized Health 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia Genomics Personalized Health 麻豆原创 Share by Application (2018-2029)
9.4 Asia Genomics Personalized Health 麻豆原创 Size by Region
9.4.1 Asia Genomics Personalized Health 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Genomics Personalized Health 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia Genomics Personalized Health 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Genomics Personalized Health 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Genomics Personalized Health Introduction
11.1.4 QIAGEN Revenue in Genomics Personalized Health Business (2018-2023)
11.1.5 QIAGEN Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Genomics Personalized Health Introduction
11.2.4 Illumina Revenue in Genomics Personalized Health Business (2018-2023)
11.2.5 Illumina Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Genomics Personalized Health Introduction
11.3.4 Thermo Fisher Scientific Revenue in Genomics Personalized Health Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Genomics Personalized Health Introduction
11.4.4 Bio-Rad Revenue in Genomics Personalized Health Business (2018-2023)
11.4.5 Bio-Rad Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Genomics Personalized Health Introduction
11.5.4 Roche Revenue in Genomics Personalized Health Business (2018-2023)
11.5.5 Roche Recent Developments
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Genomics Personalized Health Introduction
11.6.4 Lonza Revenue in Genomics Personalized Health Business (2018-2023)
11.6.5 Lonza Recent Developments
11.7 INVITAE
11.7.1 INVITAE Company Details
11.7.2 INVITAE Business Overview
11.7.3 INVITAE Genomics Personalized Health Introduction
11.7.4 INVITAE Revenue in Genomics Personalized Health Business (2018-2023)
11.7.5 INVITAE Recent Developments
11.8 Genetic Technologies
11.8.1 Genetic Technologies Company Details
11.8.2 Genetic Technologies Business Overview
11.8.3 Genetic Technologies Genomics Personalized Health Introduction
11.8.4 Genetic Technologies Revenue in Genomics Personalized Health Business (2018-2023)
11.8.5 Genetic Technologies Recent Developments
11.9 Interleukin Genetics
11.9.1 Interleukin Genetics Company Details
11.9.2 Interleukin Genetics Business Overview
11.9.3 Interleukin Genetics Genomics Personalized Health Introduction
11.9.4 Interleukin Genetics Revenue in Genomics Personalized Health Business (2018-2023)
11.9.5 Interleukin Genetics Recent Developments
11.10 Eastern Biotech
11.10.1 Eastern Biotech Company Details
11.10.2 Eastern Biotech Business Overview
11.10.3 Eastern Biotech Genomics Personalized Health Introduction
11.10.4 Eastern Biotech Revenue in Genomics Personalized Health Business (2018-2023)
11.10.5 Eastern Biotech Recent Developments
11.11 DNA Genotek
11.11.1 DNA Genotek Company Details
11.11.2 DNA Genotek Business Overview
11.11.3 DNA Genotek Genomics Personalized Health Introduction
11.11.4 DNA Genotek Revenue in Genomics Personalized Health Business (2018-2023)
11.11.5 DNA Genotek Recent Developments
11.12 UBiome
11.12.1 UBiome Company Details
11.12.2 UBiome Business Overview
11.12.3 UBiome Genomics Personalized Health Introduction
11.12.4 UBiome Revenue in Genomics Personalized Health Business (2018-2023)
11.12.5 UBiome Recent Developments
11.13 XCode Life
11.13.1 XCode Life Company Details
11.13.2 XCode Life Business Overview
11.13.3 XCode Life Genomics Personalized Health Introduction
11.13.4 XCode Life Revenue in Genomics Personalized Health Business (2018-2023)
11.13.5 XCode Life Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

QIAGEN
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Lonza
INVITAE
Genetic Technologies
Interleukin Genetics
Eastern Biotech
DNA Genotek
UBiome
XCode Life

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.